To track and analyze strategic developments such as service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions in the global market

This research study involves the extensive usage of secondary sources, directories, and databases (such as, Bloomberg Business, Factiva, and Dun & Bradstreet), in order to identify and collect information useful for this technical, market-oriented, and financial study of the stem cell banking market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

In 2017, Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International (US) held the leading position in the global stem cell banking market. In the past three years, these companies have adopted service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions as their key business strategies to ensure their market dominance. Moreover, ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico) were some of the other major players in this market, as of 2017.

This report categorizes the global stem cell banking market into the following segments and subsegments:

Global Stem Cell Banking Market, by Source

Placental Stem Cells (PSCs)

Human Embryo-derived Stem Cells (hESCs)

Bone Marrow-derived Stem Cells (BMSCs)

Adipose Tissue-derived Stem Cells (ADSCs)

Dental Pulp-derived Stem Cells (DPSCs)

Other Stem Cell Sources

Global Stem Cell Banking Market, by Application

Personalized Banking Applications

Clinical Applications

Hematopoietic Disorders

Autoimmune Disorders

Other Diseases

Research Applications

Disease Treatment Studies

Life Science Research

Drug Discovery

Global Stem Cell Banking Market, by Application

Sample Collection & Transportation

Sample Processing

Sample Analysis

Sample Preservation & Storage

Global Stem Cell Banking Market, by Region

North America

US

Canada

Europe

Germany

UK

Spain

Portugal

Rest of Europe (RoE)

Asia Pacific

China

India

South Korea

Rest of Asia-Pacific

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:

Service Portfolio

Service offering matrix; which gives a detailed comparison of the service portfolios of the top 5 companies profiled in the report

Geographic Analysis

Further breakdown of the North American stem cell banking market into US and Canada

Further breakdown of the European stem cell banking market into Germany, France, UK, and Rest of Europe (RoE)

Further breakdown of the Asia Pacific stem cell banking market into Japan, China, India, and Rest of Asia Pacific (RoAPAC)

The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%. Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market.

This report broadly categorizes the global market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into placental, bone marrow-derived, adipose tissue-derived, human embryo-derived, dental pulp, and other stem cell sources. In 2018, placental stem cells segment is expected to account for the largest share of the market. This can be attributed to the global rise in the number of placental and cord banks (especially in the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cells.

Based on application, the global market is segmented into personalized banking, clinical, and research applications. In 2018, personalized banking applications segment is expected to dominate the global stem cell banking applications market due to the premium pricing of service plans charged by service providers and specific advantages offered by personalized banking over community & public banking, growing adoption of precision medicine across developed countries, rising prevalence of blood and immune system-related disorders, and increasing public concerns regarding the clinical abuse of stored stem cell samples.

Based on service type, the global market is segmented into sample collection & transportation, sample processing, sample analysis, and sample preservation & storage. In 2018, sample preservation & storage segment is expected to be the largest service segment owing to the growing adoption of stem cell banking services in major countries coupled with the rising number of stem cell banks across emerging countries, rising public awareness about the therapeutic applications of stem cells, increasing number of hematopoietic stem cell transplantations, increasing stem cell-based research, and high market penetration of stem cell banking services in major healthcare markets.

This report covers the global market across four major regions, namely, North America, Europe, Asia Pacific, and RoW. In 2018, North America is expected to command the largest share of stem cell banking market that is mainly attributed to the expanding network of stem cell banking services, ongoing approval of stem cell lines for various disease treatment, recent technological advancements in the field of stem cell collection and preservation techniques, rising public-private investments for stem cell researches, growing number of stem cell transplantation procedures, and increasing public preference for private stem cell banking over public stem cell banks.

However, factors such as high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to limit the growth of the market during the forecast period.

As of 2017, major players in the global stem cell banking market are Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst